Lupin P/B Ratio
Lupin (LUPIN) P/B ratio is 4.19 (High), book value per share ₹2473.96 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore LUPIN fundamental worth to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
LUPIN P/B Ratio — Valuation Insights & Book Value Analysis
Lupin price-to-book ratio interpretation, valuation status and historical context — current P/B 4.19 (High). For live price, earnings yield and the full fundamental profile, see Lupin stock price NSE.
- Stock appears overvalued with PB of 4.19, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 323.2% above historical average
- Trading at premium to sector average PB of -0.01
Lupin P/B Ratio Historical Trend
LUPIN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read Lupin dividend payments for the complete payout history and dividend yield track record.
LUPIN Historical P/B Ratio — Book Value Per Share & Year-End Price
Lupin annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.84 | ₹2473.96 | ₹2083.00 | ₹22,513 | Low |
| 2025 | 1.11 | ₹1900.44 | ₹2109.50 | ₹17,294 | Moderate |
| 2024 | 1.49 | ₹1579.56 | ₹2355.70 | ₹14,374 | Moderate |
| 2023 | 0.96 | ₹1378.35 | ₹1322.95 | ₹12,543 | Low |
| 2022 | 0.55 | ₹1343.08 | ₹733.70 | ₹12,222 | Low |
LUPIN vs Healthcare Peers — P/B Ratio Comparison
Lupin P/B 4.19 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |